A year in review: new treatments and expanded indications in dermatology in 2024
Background: There are advances in dermatologic therapies every year. Innovations in new medications transform clinical practice and provide dermatologists new opportunities to enhance patient care.Methods A literature search was conducted on Drugs@FDA: FDA-Approved Drugs for the year 2024 to identif...
Saved in:
| Main Authors: | Lauren N. McGrath, Lila G. McGrath, John R. Edminister |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2025.2456528 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
2024 FDA TIDES (Peptides and Oligonucleotides) Harvest
by: Othman Al Musaimi, et al.
Published: (2025-02-01) -
A Comprehensive Overview of US-FDA-Approved Anticancer Drugs and Biologics in 2023: An Observational Study
by: Ajay Kumar Shukla, et al.
Published: (2025-01-01) -
A Search for FDA Approved Drugs with Multiple Antiemetic Targets: A Computational-Based Drug Repositioning Study
by: Abdulmajeed Yunusa*1, Albashir Tahir1,2
Published: (2025-05-01) -
Tracking protein kinase targeting advances: integrating QSAR into machine learning for kinase-targeted drug discovery
by: Rand Shahin, et al.
Published: (2025-12-01) -
Tarlatamab and the Future of Immunotherapy: A New Approach to Small Cell Lung Cancer
by: Raza Ur Rehman, MBBS, et al.
Published: (2025-01-01)